| | Business Summary | | Empyrean
Bioscience,
Inc.
markets,
sells
and
distributes
personal
care
products
that
are
intended
to
prevent
the
spread
of
infectious
disease.
The
Company
has
introduced
three
products
under
its
complete
germ
protection
program.
The
first
product,
which
was
launched
in
the
United
States
in
March
1999,
is
a
hand
sanitizer
and
first-aid
antiseptic
lotion
that
is
marketed
under
both
the
Preventx
and
Coleman
with
Advanced
Preventx
brands.
In
the
fourth
quarter
of
2000,
the
Company
began
selling
its
line
of
antibacterial
towelettes,
which
are
also
marketed
under
the
Preventx
and
Coleman
with
Advanced
Preventx
brands.
In
December
2000,
the
Company
announced
the
introduction
of
the
Coleman
Antibacterial
Surface
Disinfectant
Cleaner,
which
can
remove
most
of
the
organisms
present
on
surfaces
that
can
cause
infectious
disease. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | Empyrean
Bioscience,
Inc.
markets,
sells
and
distributes
innovative
prophylactic
personal
care
products
designed
to
prevent
the
spread
of
infectious
disease.
For
the
six
months
ended
6/30/01,
net
revenues
rose
23%
to
$549
thousand.
Net
loss
rose
43%
to
$2.1
million.
Revenues
reflect
an
increase
in
health
and
beauty
aid
sales.
Higher
loss
reflects
an
increase
in
salaries
and
benefits,
sales
promotion
and
advertising
and
professional
expenses. | | More
from
Market Guide: Significant
Developments |
| | | | FY1999 Pay | |
| Lawrence Bain, 50
Chairman | -- | Richard Adamany, 47
Pres,
CEO | $49K | Bennett Rubin, 42
Exec.
VP, COO | 49K | | Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/e/emdg.ob.gif)